To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma

被引：1
|
作者：
Goel, Sachin [1 ]
Batra, Ankur [2 ]
Singhal, Gaurang [5 ]
Goel, Snigdha [3 ,4 ]
机构：
[1] ABVIMS & Dr RML Hosp, Dept ENT, New Delhi, India
[2] Royal Hmapshire Cty Hosp, Dept ENT, Winchester, England
[3] ABVIMS, Dept ENT, New Delhi, India
[4] Dr Ram Manohar Lohia Hosp, New Delhi, India
[5] Act Care Hosp, Dept pathol, New Delhi, India
来源：
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY | 2023年 / 75卷 / 02期
关键词：
Glottic carcinoma; PTEN; EGFR; HER2; Microarray; LARYNGEAL-CANCER; EXPRESSION; PROTEIN; HEAD; C-ERBB-2; BREAST; GENE;
D O I：
10.1007/s12070-022-03455-w
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Laryngeal carcinoma is the most common site of malignancy in head and neck region worldwide. Surgical options are limited in cases of laryngeal malignancy and moajority of cases are treated with chemoradiotherapy. Targeted therapy is an evolving novel approach to treat laryngeal carcinoma. The study was conducted to evaluate the role of PTEN, EGF and HER2 in early glottic squamous cell carcinoma cases. 52 samples of early glottis carcoinoma were collected in UCMS and GTB hospital, New Delhi after patients had undergone CO2 laser excision at the centre. Histopathologic and IHC examination was conducted on the specimen for PTEN, EGFR and HER2 molecules. PTEN was negative in 82.69% cases compared to the stroma with three year local control rate of 72.09%. EGFR was positive in 67.31% samples with three year local control rate of 68.57%. HER2 was negative in all the samples. PTEN and EGFR can be used as prognostic markers as well as novel agents for targeted therapy in the future.
引用
收藏
页码：707 / 712
页数：6
相关论文
共 50 条
  • [1] To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma
    Sachin Goel
    Ankur Batra
    Gaurang Singhal
    Snigdha Goel
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 707 - 712
  • [2] HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma
    Schlauder, Scott M.
    Calder, Kenneth B.
    Moody, Patricia
    Morgan, Michael B.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2007, 29 (06) : 559 - 563
  • [3] The immunoexpression of EGFR and Her2/neu in oral squamous carcinoma
    Dragomir, L. P.
    Margaritescu, Cl.
    Florescu, Alma
    Olimid, A. D.
    Dragomir, Manuela
    Popescu, M. R.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (03): : 597 - 601
  • [4] Gene amplification of EGFR, HER2, HER3 and HER4 in esophageal squamous cell carcinoma
    Kato, Hiroaki
    Arao, Tokuzo
    Matsumoto, Kazuko
    Fujita, Yoshihiko
    Kimura, Hideharu
    Nishiki, Kouhei
    Shiraishi, Osamu
    Yasuda, Atsushi
    Peng, Ying-Feng
    Shinkai, Masayuki
    Imano, Motohiro
    Imamoto, Haruhiko
    Yasuda, Takushi
    Okuno, Kiyotaka
    Shiozaki, Hitoshi
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [5] Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
    Kato, Hiroaki
    Arao, Tokuzo
    Matsumoto, Kazuko
    Fujita, Yoshihiko
    Kimura, Hideharu
    Hayashi, Hidetoshi
    Nishiki, Kouhei
    Iwama, Mitsuru
    Shiraishi, Osamu
    Yasuda, Atsushi
    Shinkai, Masayuki
    Imano, Motohiro
    Imamoto, Haruhiko
    Yasuda, Takushi
    Okuno, Kiyotaka
    Shiozaki, Hitoshi
    Nishio, Kazuto
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (04) : 1151 - 1158
  • [6] Expressions of EGFR, HER2, and HER3 and their correlations with clinical characteristics in oropharyngeal squamous cell carcinoma (OPSCC).
    Saba, Nabil F.
    Qian, Guoquing
    Ning, Jiang
    Kim, Sungjin
    Chen, Zhengjia
    Garcia, Gabriela
    MacBeath, Gavin
    Shin, Dong Moon
    Khuri, Fadlo Raja
    Chen, Zhuo Georgia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma
    Zhou, Liang
    Le, Kehao
    Chen, Qianming
    Wang, Huiming
    BMC ORAL HEALTH, 2024, 24 (01):
  • [8] Role of EGFR but not HER2 or HER3 gene copy number in predicting sensitivity of head and neck squamous cell carcinoma (SCCHN) cell lines to EGFR tyrosine kinase inhibitors
    Varella-Garcia, M.
    Acheson, K.
    Marshall, G. B.
    McCormack, R. M.
    Ryan, A.
    Hirsch, F. R.
    Bunn, P. A., Jr.
    Hickinson, D. M.
    Speake, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] The expression of EGFR, HER2 and EpCam in Head and Neck squamous cell carcinomas
    Schartinger V.H.
    Schmutzhard J.
    Wurm M.
    Schwentner I.M.
    Obrist P.
    Oberaigner W.
    Sprinzl G.M.
    memo - Magazine of European Medical Oncology, 2009, 2 (1) : 45 - 50
  • [10] Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx
    Denitsa Krasimirova Koynova
    Vesselina Sainova Tsenova
    Renata Stoiancho Jankova
    Plamen Borisov Gurov
    Draga Ivanova Toncheva
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 199 - 203
12345